Editorial: Interferon response against viral infections
Ana Maria Ortega-Prieto,Jose Angel Regla-Nava,Jose M. Jimenez-Guardeño
DOI: https://doi.org/10.3389/fmicb.2024.1496035
IF: 5.2
2024-10-11
Frontiers in Microbiology
Abstract:Viral infections are marked by a constant battle between the invading virus and the infected host.The outcome of this engagement heavily relies on the exploitation of host-encoded factors, which viruses leverage to grow and spread, and the host's immune response, which aims to suppress and eliminate the infection. Among the host defences, the interferon (IFN) response stands out as a crucial early barrier, mediating the induction of an antiviral state in the cells by leading to the upregulation of a wide range of IFN-stimulated genes (ISGs) with antiviral properties. On the other hand, to establish a successful infection, many viruses have evolved sophisticated strategies to evade these immune responses by targeting various elements of the innate immune system, thereby allowing them to persist and replicate within the host. In brief, IFNs are essential proteins that, via several mechanisms, regulate cell growth and the inflammatory innate response, and possess immunomodulatory activity and physiological functions. Understanding the molecular mechanisms underlying the innate immune response to viral infections is essential for uncovering points of viral vulnerability, which could guide the development of novel antiviral therapies. This research topic aimed to highlight recent advancements in our understanding of the molecular mechanisms that regulate the host's innate immune response to viral infections. We welcomed contributions across a range of formats, including reviews, original research articles, methods, short communications, case reports, and opinions. In total, the selected articles published in this research topic include five research articles and two reviews. Interestingly, HBx plays a significant role in disrupting the production of crucial mediators in the antiviral immune response involved in the IFN signalling cascade, such as RIG-I and the interferon regulatory factor 3 (IRF3), effectively inhibiting their function and preventing the activation of antiviral pathways. This interference not only reduces the production of IFN but also impairs downstream signalling, compromising the host's ability to generate an effective immune response against HBV. The review highlights the complex mechanisms by which HBx regulates HBV replication and its critical influence on the IFN signalling pathway, as well as its role in hepatocellular carcinoma metastasis and invasion. While the complexity of HBx's interactions with host immune responses presents significant challenges that must be addressed to translate these insights into effective therapeutic strategies, this understanding provides a crucial foundation for advancing future research and developing therapeutics that specifically target HBx.In their review, Liu et al. explore the unique role of type III IFN (IFN-λ), a relatively new addition to the IFN family, in antiviral immunity against respiratory viral infections. Unlike type I IFNs, which are widely known for their antiviral functions, IFN-λ operates predominantly at mucosal surfaces, particularly in epithelial cells, and plays a non-redundant role in preventing viral spread.Interestingly, the review highlights the promising therapeutic potential of targeting IFN-λ to enhance respiratory mucosal immunity. However, further clinical trials are essential to validate these findings and fully understand the implications for antiviral therapies.Zhang et al. investigated the isolation of Limosilactobacillus mucosae G01, a lactic acid bacterium, from the faecal microbiota of Bama pigs and its antiviral properties against porcine epidemic diarrhea virus (PEDV), a major cause of severe diarrhea in piglets that leads to substantial economic losses in the pig farming industry. Their study revealed that L. mucosae G01 exhibits potent inhibitory effects PEDV by enhancing the phosphorylation of IRF3 in IPEC-J2 cells, which in turn induces the production of various IFNs (IFN-α, IFN-β, IFN-λ1 and IFN-λ3). Additionally, the upregulation of ISGs such as MX1, MX2, OAS1, and ZAP was observed in a dose-dependent manner, demonstrating a robust antiviral response and effectively mitigating PEDV replication. This work suggests that L. mucosae G01 could serve as a promising and naturally derived alternative for controlling PEDV and potentially other enteric coronavirus infections. However, the scalability and clinical efficacy of such probiotic therapies remain a limitation to be addressed.in the context of cervical lesions. Their research revealed that co-infection with cervical fungi may decrease the risk of cervical lesions, compared to HPV infection alone, suggesting that fungal infection might mitigate the effect of HPV that enhances lesion development. Specifically, the study found that co-infected individuals had a 27% lower risk of developing low-grade squamous intraepithelial lesions (LSIL), a 35% lower risk for high-grade squamous intraepithelial lesions (HSIL), a -Abstract Truncated-
microbiology